Lineage Cell Therapeutics, Inc. Share Price
Stocks
LCTX
US53566P1093
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.350 USD | +3.85% |
|
+10.66% | -19.16% |
| 30/06 | Lineage Cell Therapeutics, Inc.(NYSEAM:LCTX) added to Russell Small Cap Comp Growth Benchmark | CI |
| 29/06 | Lineage Cell Therapeutics, Inc.(NYSEAM:LCTX) added to Russell 2000 Index | CI |
| Market Cap | 34Cr 29Cr 27Cr 25Cr 48Cr 3.2TCr 49Cr 324.6Cr 126.19Cr 1.58TCr 126.33Cr 123.62Cr 5.43TCr | P/E 2026 * |
-19.3x | P/E 2027 * | -14.8x |
|---|---|---|---|---|---|
| Enterprise Value | 34Cr 29Cr 27Cr 25Cr 48Cr 3.2TCr 49Cr 324.6Cr 126.19Cr 1.58TCr 126.33Cr 123.62Cr 5.43TCr | EV / Sales 2026 * |
18.8x | EV / Sales 2027 * | 18.6x |
| Free-Float |
95.07% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Lineage Cell Therapeutics, Inc.
| 1 day | +3.85% | ||
| 1 week | +10.66% | ||
| Current month | +3.05% | ||
| 1 month | +11.57% | ||
| 3 months | -14.01% | ||
| 6 months | -17.68% | ||
| Current year | -19.16% |
| 1 week | 1.29 |  | 1.37 |
| 1 month | 1.18 | | 1.37 |
| Current year | 1.18 | | 1.98 |
| 1 year | 0.93 | | 2.09 |
| 3 years | 0.37 | | 2.09 |
| 5 years | 0.37 | | 2.81 |
| 10 years | 0.37 | | 4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Brian Culley
CEO | Chief Executive Officer | 54 | 17/09/2018 |
Jill Howe
DFI | Director of Finance/CFO | 50 | 14/11/2022 |
| Chief Operating Officer | - | 01/12/2010 |
| Director | Title | Age | Since |
|---|---|---|---|
Neal Bradsher
BRD | Director/Board Member | 60 | 01/07/2009 |
Deborah Andrews
BRD | Director/Board Member | 68 | 11/04/2014 |
Michael Mulroy
CHM | Chairman | 60 | 27/04/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/03 | Buy | Chief Executive Officer | 15,000 | 0.0065% | ||
| 05/03 | Free | Chief Financial Officer | 10,50,000 | 0.4559% | ||
| 05/03 | Free | Chief Executive Officer | 32,50,000 | 1.4110% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.85% | +10.66% | +32.35% | -4.26% | 34Cr | |
| +1.70% | +6.89% | +2.76% | +7.65% | 4.91TCr | |
| +0.92% | +6.21% | +408.85% | +607.44% | 4.02TCr | |
| +1.89% | +11.06% | +25.75% | -7.89% | 3.46TCr | |
| +2.38% | +8.10% | +21.83% | +66.94% | 3.31TCr | |
| +3.96% | +6.07% | +14.14% | +37.68% | 2.52TCr | |
| +2.51% | +4.94% | - | - | 1.7TCr | |
| +2.58% | +7.24% | +71.03% | +132.17% | 1.59TCr | |
| +0.32% | +1.58% | +14.34% | +19.26% | 1.38TCr | |
| -1.14% | +7.52% | +14.75% | -30.83% | 1.33TCr | |
| Average | +1.86% | +6.46% | +67.31% | +92.02% | 2.43TCr | |
| Weighted average by Cap. | +1.74% | +6.32% | +89.06% | +131.53% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.79Cr 1.57Cr 1.44Cr 1.34Cr 2.55Cr 170.79Cr 2.59Cr 17Cr 6.73Cr 84Cr 6.73Cr 6.59Cr 289.29Cr | 1.81Cr 1.58Cr 1.45Cr 1.35Cr 2.57Cr 172.27Cr 2.61Cr 17Cr 6.78Cr 85Cr 6.79Cr 6.65Cr 291.8Cr |
| Net income | -2.38Cr -2.08Cr -1.91Cr -1.78Cr -3.38Cr -226.5Cr -3.43Cr -23Cr -8.92Cr -111.34Cr -8.93Cr -8.74Cr -383.65Cr | -3.17Cr -2.77Cr -2.54Cr -2.37Cr -4.5Cr -301.45Cr -4.57Cr -31Cr -12Cr -148.18Cr -12Cr -12Cr -510.61Cr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/26/02 | $1.350 | +3.85% | 7,24,037 |
| 01/26/01 | $1.300 | -0.76% | 7,75,272 |
| 30/26/30 | $1.310 | -2.96% | 8,65,791 |
| 29/26/29 | $1.350 | +5.47% | 14,68,523 |
| 26/26/26 | $1.280 | +4.92% | 2,25,39,712 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LCTX Stock
Select your edition
All financial news and data tailored to specific country editions
